Free Trial
NYSE:JATT

JATT Acquisition (JATT) Stock Price, News & Analysis

JATT Acquisition logo
$1.77 -0.03 (-1.67%)
As of 01/17/2025

About JATT Acquisition Stock (NYSE:JATT)

Key Stats

Today's Range
$1.76
$1.85
50-Day Range
$1.77
$8.16
52-Week Range
$7.80
$12.38
Volume
393,546 shs
Average Volume
41,322 shs
Market Capitalization
$30.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

JATT Acquisition Corp does not have significant operations. It intends to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company intends to focus on businesses primarily operating in the life sciences sector. JATT Acquisition Corp was incorporated in 2021 and is based in Grand Cayman, the Cayman Islands.

Receive JATT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for JATT Acquisition and its competitors with MarketBeat's FREE daily newsletter.

JATT Stock News Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Zura Bio (ZURA) Receives a Buy from Piper Sandler
See More Headlines

JATT Stock Analysis - Frequently Asked Questions

JATT Acquisition's stock was trading at $2.50 on January 1st, 2025. Since then, JATT shares have decreased by 29.2% and is now trading at $1.77.
View the best growth stocks for 2025 here
.

Shares of JATT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
1/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Net Income
$6.85 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.07 per share
Book Value
($0.53) per share

Miscellaneous

Free Float
13,800,000
Market Cap
$30.53 million
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NYSE:JATT) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners